Evidence map›Paper›PMID 37111380›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease.

Gi-Ae Kim, Hyun Chin Cho, Soung Won Jeong, Bo-Kyeong Kang, Mimi Kim, Seungwon Jung, Jungwook Hwang, Eileen L Yoon, Dae Won Jun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Gi-Ae KimDepartment of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.
Hyun Chin ChoDepartment of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju 52727, Republic of Korea.
Soung Won JeongDepartment of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Seoul Hospital, Seoul 04401, Republic of Korea.
Bo-Kyeong KangDepartment of Radiology, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.
Mimi KimDepartment of Radiology, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.ORCID 0000-0002-8266-0226
Seungwon JungGraduate School for Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Jungwook HwangGraduate School for Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.ORCID 0000-0002-2290-1649
Eileen L YoonHanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Republic of Korea.
Dae Won JunHanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Republic of Korea.ORCID 0000-0002-2875-6139
Hanyang University · KRGyeongsang National University Hospital · KRKyung Hee University · KRSoonchunhyang University Hospital Seoul · KR

Funding

AngioLab, Inc. NA
6 · The paper itself

Abstract

Preclinical data have shown that the herbal extract, ALS-L1023, from

Indexed as

ALS-L1023non-alcoholic fatty liver diseasenon-alcoholic steatohepatitis

Identifiers

PMID37111380
PMCPMC10142612
OpenAlexW4366774629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.